Exela Technologies Announces New Logo with L’Assurance Maladie Caisse Nationale, the French National Insurance Fund
June 28 2022 - 7:00AM
Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA, XELAP),
today announced a contract with L’Assurance Maladie Caisse
Nationale (“Cnam”), the French National Insurance Fund, utilizing
Exela’s PCH Global platform to speed up the National Agency’s
digital transformation. While the initial total contract value
(“TCV”) is $2.5 million, the 4-year contract has the potential to
grow to over $4.5 million over this period.
Initially, the solution will deploy Exela’s cutting-edge Raptor
and Intelliscan XDS scanners as well as a full OCR application
across multiple sites as part of Exela ITPS (Information and
Transaction Processing Solutions) segment. The online
classification and extended sorting capacity will handle a wide
range of document types and the initial deployment will be rolled
out to two sites within 2022, with estimated volumes of 40,000
pieces per site per day, therefore optimizing social security and
healthcare claims processing and management in France.
“As part of its modernization efforts and new policy, the Caisse
Nationale de l'Assurance Maladie decided to make the processing of
its non-digital incoming flows more efficient. The PLEIADE project
(Plateforme Electronique d'Intégration des Courriers Incrants et
d'Archivage Dématérialisé) was launched to achieve this goal. We
are delighted to have chosen Exela Technologies as our digital
partner to support us in this transformation project. Our choice
was guided by Exela’s technological expertise within the
digitalization of workflows and the alignment of the solution to
the wide variety of documents we processed in high volumes,” said
Mr. Karim Ben Ali, Project Director of the PLEIADE project.
“While many global economies, especially in Europe, have been
experiencing high levels of inflation, customers are attracted to
Exela’s cost and time-saving digital transformation solutions. We
are always excited to sign new logos and help customers began their
digital journey and we look forward to growing with L’Assurance
Maladie Caisse Nationale,” said Vitalie Robu, President of Exela
EMEA.
About Cnam
The Caisse Nationale de l'Assurance Maladie des travailleurs
salariés (Cnam) is a public administrative body whose mission is to
define health insurance policy at national level. Its role is to
steer, coordinate and advise the action of the local bodies that
make up its network, in particular, the primary health insurance
funds (CPAM) and the five general social security funds.
About Exela Technologies
Exela Technologies is a business process automation (BPA)
leader, leveraging a global footprint and proprietary technology to
provide digital transformation solutions enhancing quality,
productivity, and end-user experience. With decades of experience
operating mission-critical processes, Exela serves a
growing roster of more than 4,000 customers throughout 50
countries, including over 60% of the Fortune® 100. Utilizing
foundational technologies spanning information management, workflow
automation, and integrated communications, Exela’s software and
services include multi-industry, departmental solution suites
addressing finance and accounting, human capital management, and
legal management, as well as industry-specific solutions for
banking, healthcare, insurance, and the public sector. Through
cloud-enabled platforms, built on a configurable stack of
automation modules, and approximately 17,000 employees operating in
23 countries, Exela rapidly deploys integrated technology
and operations as an end-to-end digital journey partner
For more Exela news, commentary, and industry
perspectives,
visit: https://investors.exelatech.com/
And please follow us on social:
Twitter: https://twitter.com/exelatech
LinkedIn: https://www.linkedin.com/company/exela-technologies
Facebook: https://www.facebook.com/exelatechnologies/
Instagram: https://www.instagram.com/exelatechnologies
The information posted on the Company's website and/or via its
social media accounts may be deemed material to investors.
Accordingly, investors, media and others interested in the Company
should monitor the Company's website and its social media accounts
in addition to the Company's press releases, SEC filings
and public conference calls and webcasts.
Forward-Looking Statements
Certain statements included in this press release are not
historical facts but are forward-looking statements for purposes of
the safe harbor provisions under The Private Securities Litigation
Reform Act of 1995. Forward-looking statements generally are
accompanied by words such as "may", "should", "would", "plan",
"intend", "anticipate", "believe", "estimate", "predict",
"potential", "seem", "seek", "continue", "future", "will",
"expect", "outlook" or other similar words, phrases or expressions.
These forward-looking statements include statements regarding our
industry, future events, estimated or anticipated future results
and benefits, future opportunities for Exela, and other
statements that are not historical facts. These statements are
based on the current expectations of Exela management and
are not predictions of actual performance. These statements are
subject to a number of risks and uncertainties, including without
limitation those discussed under the heading "Risk Factors"
in Exela's Annual Report and other securities filings. In
addition, forward-looking statements
provide Exela's expectations, plans or forecasts of
future events and views as of the date of this
communication. Exela anticipates that subsequent events
and developments will cause Exela's assessments to
change. These forward-looking statements should not be relied upon
as representing Exela's assessments as of any date
subsequent to the date of this press release.
Investor and/or Media Contacts:
Vincent KondaveetiE: vincent.kondaveeti@exelatech.com
Mary Beth BenjaminE: IR@exelatech.com
Exela Technologies (NASDAQ:XELA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exela Technologies (NASDAQ:XELA)
Historical Stock Chart
From Sep 2023 to Sep 2024